Abbott India share price
You have to be logged in to add this to Watchlist.- ₹34,185.75(0.02%)July 17, 2025 12:16:02 PM IST
- NSE
- BSE
- Vol : 3.33K (NSE + BSE)Last 20 day avg : 12.73 K
Abbott India is trading 0.02% upper at Rs 34,185.75 as compared to its last closing price. Abbott India has been trading in the price range of 34,406.95 & 34,175.80. Abbott India has given 15.26% in this year & -0.32% in the last 5 days. Abbott India has TTM P/E ratio 46.15 as compared to the sector P/E of 23.12.There are 6 analysts who have initiated coverage on Abbott India. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 367.04 Crores in its last quarter.Listed peers of Abbott India include Zydus Lifesciences (1.31%), Lupin (1.45%), Abbott India (0.02%).The Mutual Fund holding in Abbott India was at 7.77% in 30 Jun 2025. The MF holding has increased from the last quarter. The FII holding in Abbott India was at 0.16% in 30 Jun 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jul 17, 2025, 07:14 AM UTC
- Dividend YieldHigher than industry1.37Annual dividends as a percentage of the stock price.
- P/BHigher than historical values17.44The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values52.18Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.07Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 11.54% from Rs 1604.59 crore to Rs 1438.63 crore, year-on-year
- The company has grown its March quarter profit by 27.86% from Rs 287.06 crore to Rs 367.04 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
- R1
- 36,432.67
- R2
- 37,227.88
- R3
- 38,534.22
- S1
- 34,331.12
- S2
- 33,024.78
- S3
- 32,229.57
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | Bullish | 981.30 | 1.31 | 98,741.74 | 21.43 | 4.2 | 1.10 | 0.13 |
| Lupin | Neutral | 1,957.65 | 1.45 | 89,409.04 | 27.27 | 5.19 | 0.41 | 11.80 |
| Abbott India | Bullish | 34,185.75 | 0.02 | 72,827.10 | 53.21 | 17.78 | 1.34 | 3.73 |
| Alkem Laboratories | Moderately Bullish | 5,017.40 | 0.35 | 59,934.42 | 26.62 | 4.81 | 0.93 | 4.83 |
| Glaxosmithkline Pharmaceutical | Neutral | 3,177.40 | 0.42 | 53,808.32 | 60.53 | 28.67 | 1.27 | 0.13 |
- Promoter(s) holds a high stake in the company at 74.99%
- FIIs are invested in this company
- FIIs holding is constant over the last quarter at 0.16%
- Mutual Funds holding has increased by 0.04 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-07 | Quarterly Results |
| 2024-05-09 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE358A01014
- BSE Code500488
- NSE CodeABBOTINDIA
Abbott India is trading at 34185.75 as on Thu Jul 17 2025 06:46:02. This is 0.02% upper as compared to its previous closing price of 34179.35.
The market capitalization of Abbott India is 72827.10 Cr as on Thu Jul 17 2025 06:46:02.
The 52 wk high for Abbott India is 35921.55 whereas the 52 wk low is 25260.20
Abbott India can be analyzed on the following key metrics -
- TTM P/E: 46.15
- Sector P/E: 23.12
- Dividend Yield: 1.39%
- D/E ratio: 0.05
Abbott India reported a net profit of 1414.44 Cr in 2025.
The Mutual Fund Shareholding was 7.77% at the end of 30 Jun 2025.